Interferon-γ: Biologic functions and HCV therapy (type I/II) (1 of 2 parts)

Clinica Terapeutica

Volumn 157, Issue 4, 2006, Pages 377-386

  Gattoni, Adriano ^a,b   Parlato, A ^a   Vangieri, B ^a   Bresciani, M ^a   Derna, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

IFN R; Interferon gamma; Major histocompatibility complex (MHC); Natural killer(NK); Th cells

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; GLUCOCORTICOID; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CELLULAR IMMUNITY; CYTOLYSIS; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PROTEIN SECRETION; REVIEW;

HEPATITIS C; HUMANS; INTERFERON TYPE II; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES;

EID: 33845539851     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (138)

1. Rubinstein M, Levy W, Moschera J, et al.: Human leukocyte interferon: Isolation and characterisation of several molecular forms. Arch Biochem Biophys 1981; 210:307-18
2. Payne M, Leadbeater L, Brand CM, et al.: The composition of lymphoblastoid interferon (Wellferon). J Interferon Res 1990; 10:8263
3. Zoon K, Miller D, Bekisz J, et al.: Purification and characterisation of multiple components of human lymphoblastoid interferon alpha. J Biol Chem 1992; 267:15210-6
4. Hiscott J, Cantell K, Weissman C: Differential expression of human interferon genes. Nucleic Acid Res 1984; 12:3727-46
5. Hauptman R, Sweetly P: A novel class of human type I interferons. Nucleic Acid Res 1985; 13:4739-49
6. Pestka S, Langer J, Zoon K, et al.: Interferon and their actions. Annu Rev Biochem 1987; 56:727-7
7. Staeheli P.: Interferon induced proteins and the anti-viral state. Adv Virus Res 1990; 38:147-200
8. Mueller U, Steinhoff U, Reis L, et al.: Targeted disruption of the murine type I interferon receptor gene. Science 1993;264:1918-21
9. Trinchieri G, Perussia B: Immune interferon: A pleitropic lymphokine with multiple effects. Immunol Today 1985; 6:131-6
10. Jung V, Rashidbaigi A, Jones C, et al.: Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc Natl Acad Sci U S A 1987; 84:4151-5
11. Farrar MA, Fernandez-Luna J, Schreiber RD: Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function. J Biol Chem 1991; 266:19626-35
12. Kotenko SV, Izotova LS, Pollack BP, et al.: Interaction between the components of the interferon gamma receptor complex. J Biol Chem 1995; 270:20915-21
13. Marsters SA, Pennica D, Bach E, et al.: Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci USA 1995; 92:5401-5
14. Pestka S, Kotenko SV, Muthukumaran G, et al.: The interferon gamma receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev 1997; 8:189-206
15. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87:6934-8
16. Walter MR, Windsor WT, Nagabhushan TL, et al.: Crystal structure of a complex between interferon-gamma and its soluble high affinity receptor. Nature 1995; 376:230-5
17. 2, with its receptor. J Biol Chem 1994; 269:4333-6
18. 1 binding. J Biol Chem 1996; 271:9-12
19. Greenlund AC, Ferrar MA, Viviano BL, et al.: Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J 1994; 13:1591-600
20. Bach EA, Tanner JW, Marsters S, et al.: Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol 1996; 16:3214-21
21. 1 can sustain interferon-gamma inducible gene expression but not an antiviral state. EMBO J 1996; 15:799-809
22. Greenlund AC, Morales MO, Viviano BL, et al.: STAT recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 1995; 2:677-87
23. 2 groups to specific interferon signaling by the JAK STAT pathway. Science 1995; 267:1347-9
24. 91 required for gene activation by interferon gamma. Science 1993; 261:1744-6
25. 91-KD DNA binding protein. Science 1992; 258:1808-12
26. Briscoe J, Gushin D, Rogers NC, et al.: JAKs, STATs and signal transduction in response to the interferons and other cytokines. Philos Trans R Soc Lond B Biol Sci 1996; 351:167-71
27. Novelli F, Bernabei P, Ozmen L, et al.: Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha-and beta-chains of its receptor. J Immunol 1996; 157:1935-43
28. Bach EA, Szabo SJ, Dighe AS, et al.: Ligand induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 1995; 270:1215-8
29. 1 cells. Science 1995; 269:245-7
30. Groux H, Sornasse T, Cottrez F, et al.: Induction of human T helper cell type 1 differentiation results in loss of IFN gamma receptor beta-chain expression. J Immunol 1997; 158:5627-31
31. Starr R, Willson TA, Viney EM, et al.: A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387:917-21
32. 2 domain that inhibits JAK kinases. Nature 1997; 387:921-4
33. Naka T, Narazaki M, Hirata M, et al.: Structure and functions of a new STAT induced STAT inhibitor. Nature 1997; 387:924-9
34. Sakamoto H, Yasukawa H, Masuhara M, et al.: A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 1998; 92:1668-76
35. 3 requires both tyrosine and serine phosphorylation. Cell 1995; 82:241-50
36. 2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins. Science 1995; 269:1721-3
37. 1 by the ubiquitin-proteasome pathway. Science 1997; 273:1717-9
38. Boehm U, Klamp T, Grant M, et al.: Cellular esponses to interferon gamma. Annu Rev Immunol 1997; 15:749-95
39. Belich MP, Glynne RJ, Sanger G, et al.: Proteasome components with reciprocal expression to that of the MHC encoded LMP proteins. Curr Biol 1994; 4:769-76
40. Hisamatsu H, Shimhara N, Saita Y, et al.: Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J Exp Med 1996; 183:807-16
41. Strobl B, Arulampalam V, Hern F, et al.: A completely foreign receptor can mediate an interferon gamma-like response. EMBO J 2001; 83:5431-42
42. Groettrup M, Khan S, Schwarz K, et al.: Interferon gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 2001; 83:367-72
43. Groettrup M, Soza A, Eggers M, et al.: A role for the proteasome regulator PA28alpha in antigen presentation. Nature 1996; 381:166-8
44. Epperson DE, Arnold D, Spies T, et al.: Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endhothelial cells. J Immunol 1992; 149:3297-301
45. Decker T, Stockinger S, Karaghiosoff M, et al.: IFNs and STATs in innate immunity to microorganisms. J Clin Invest 2002; 109:1271-7
46. Shirayoshi Y, Burke PA, Appella E, et al.: Interferon induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc. Natl. Acad. Sci. USA 1988; 85:5884-8
47. Seder RA, Gazzinelli RT: Cytokines are critical in linking the innate and adoptive immune responses to bacterial, fungal and parasitic infection. Adv Intern Med 1999; 44:353-8
48. Kern I, Steimle V, Siegrist CA, et al.: The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int Immunol 1995; 7:1295-9
49. Chang CH, Flavell RA: Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp Med 1995; 181:765-7
50. Wolf PR, Ploegh HL: How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 1995; 11:267-306
51. Lah TT, Hawley M, Rock KL, et al.: Gamma interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages. FEBS Lett 1995; 363:85-9
52. Lafuse WP, Brown D, Castle L, et al.: IFN-gamma increases cathepsin H mRNA levels in mouse macrophages. J Leukoc Biol 1995; 57:663-9
53. York IA, Rock KL: Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996; 14:369-96
54. Grandea III AG, Androlewiez MJ, Athwal RS, et al.: Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 1995; 270:105-8
55. Suto R, Srivastava PK: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269:1585-8
56. Chang CH, Guerder S, Hong SC, et al.: Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996; 4:167-78
57. Waldburger JM, Masternak K, Muhlethaler-Mottet A, et al.: Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev 2000;178:148-65
58. Boss JM. Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997; 9:107-13
59. Mc Micking J, Xie Q, Nathan C: Nitric oxide and macrophage function. Ann Rev Immunol 1997; 15:323-50
60. Baek KJ, Thiel BA, Lucas S, et al.: Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem 1993; 268:21120-9
61. Cassatella MA, Bazzoni F, Flynn RM, et al.: Molecular basis of interferon gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J Biol Chem 1990; 265:20241-6
62. Newburger PE, Ezekowitz RA, Whitney C, et al.: Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma. Proc Natl Acad Sci USA 1988; 85:5215-9
63. Strunk RC, Cole FS, Perlmutter DH, et al.: Gamma-interferon increases expression of class II complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J Biol Chem 1985; 260:15280-5
64. Nathan CF, Gabay J.: Antimicrobial mechanisms of macrophages. In Mononuclear Phagocytes: Biology of Monocytes and Macrophages (R. Van Furth, ed.). Dordrecht. The Netherlands, Kluwer Academic, 1992; 16:259-67
65. Shiloh MU, Mac Micking JD, Nicholson S, et al.: Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999; 19:29-38
66. Karupiah G, Xie QW, Buller RM, et al.: Inhibition of viral replication by interferon gamma induced nitric oxide synthase. Science 1993; 261:1445-8
67. Green SJ, Nacy CA, Meltzer MS: Cytokine induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol 1991; 50:93-103
68. Denis M: Tumor necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991; 49:380-7
69. Wei XQ, Charles IG, Smith A, et al.: Altered immune responses in mice lacking inducible nitic oxide shyntase. Nature 1995; 375:408-11
70. Karupiah G, Chen JH, Nathan CF, et al.: Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J Virol 1998; 72:7703-6
71. Kwon NS, Nathan CF, Stuehr DJ: Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 1989; 264:20496-501
72. Drapier JC, Wietzerbin J, Hibbs Jr. Interferon gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988; 18:1587-92
73. Morris SM, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994; 266: E829-E839
74. Kamijo R, Shapiro D, Huang S, et al.: Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci USA 1993; 90:6626-30
75. Kamijo R, Harada H, Matsuyama T, et al.: Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263:1612-5
76. Radi R, Beckman JS, Bush KM, et al.: Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288:481-7
77. Pfefferkorn ER: Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81:908-12
78. Geraghty D: Complete sequence and gene map of a human major histocompatibilility complex: The MHC sequencing consortium. Nature 1999; 401:921-3
79. Jones EY: MHC class I and class II structures. Curr Opin Immunol 1997; 9:75-9
80. Pamer E, Creaawell P: Mechanisms of MHC class I restricted antigrn processing. Annu Rev Immunol 1998; 16:323-58
81. Pieters J: MHC class II restricted antigen presentation. Curr Opin Immunol 1997; 9:89-96
82. Bour H, Peyron E, Gaucherand M, et al.: Major histocompatibility complex class I restricted CD8+ T cells and class II restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995; 25:3006-10
83. Heemels MT, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995; 64:463-91
84. Lehner PJ, Cresswell P: Processing and delivery of peptides presented by MHC class I molecules. Curr Opin Immunol 1996; 8:59-67
85. York IA, Rock KL: Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996; 14:369-96
86. Chapman HA: Endosomal proteolysis and MHC class II function. Curr Opin Immunol 1999; 10:93-102
87. Hemmer J, Sturniolo T, Sinigaglia F: HLA class II binding specificity and autoimmunity. Advances in Immunology 1997; 66:67-100
88. Cresswell P: Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994; 12:259-93
89. Boehm U, Klamp T, Groot M, et al.: Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15:749-95
90. Billiau A, Heremans H, Vermeire K, et al.: Immunomodulatory properties of interferon-gamma. An update. Annu NY Acad Sci 1998; 856:22-32
91. Fruh K, Yang Y: Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol 1999; 11:76-81
92. Pierre-Audigier C, Jouanguy E, Lamhamedi S, et al.: Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clinic Infect Dis 1997; 24:982-4
93. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired response. Science 1996; 272:50-3
94. Hoffmann JA: Phylogenetic perspectives in innate immunity. Science 1999; 284:1313-8
95. Lu B, Ebensperger C, Dembic Z, et al.: Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci USA 1998; 95:8233-8
96. Faltynek CR, Princler GL: Modulation of interferon-alpha and interferon-gamma receptor expression during T-lymphocyte activation and proliferation. J Interferon Res 1986; 6:639-53
97. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998; 392:245-52
98. Mellman I: Antigen processing for amateurs and professionals. Trends Cell Biol 1998; 8:231-7
99. Voigt V, Andrews VM, Brizard G, et al: Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005; 10:1011-9
100. Sprent J: Antigen-presenting cells. Professionals and amateurs. Curr Biol 1995; 10:1095-7
101. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995; 144:245-68
102. Willenborg DO, Fordham S, Bernard CC, et al.: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996; 157:3223-7
103. Hass C, Ryffel B, Le Hir M: IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol 1997; 158:5484-91
104. 2, with its receptor. J Biol Chem 1994; 269:14333-6
105. 91 required for gene activation by interferon-gamma. Science 1993; 261:1744-6
106. Schindler C, Shuai K, Prezioso VR, et al.: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992; 257:809-13
107. Darnell JE Jr, Kerr IM, Srrak GR. JAK-STAT pathways and transcriptional activation in response to EFNs and other extracellular signaling proteins. Science 1994; 264:1415-21
108. Tough DF, Sprent J: Turnover of naive-and memory-phenotype T cells. J Exp Med 1994; 179:1127-35
109. Sprent J: Lifespans of naive, memory and effector lymphocytes. Curr Opin Immunol 1993; 5:433-8
110. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12:635-73
111. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93
112. Mosmann TR, Cherwinski H, Bond MW, et al.: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57
113. Nathan CF, Murray HW, Wiebe ME, et al.: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158:670-89
114. Deckert-Schulter M, Rang A, Weiner D, et al.: Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab Invest 1996; 75:827-41
115. Albina JE, Abate JA, Henry WL Jr.: Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunology 1991; 147:144-8
116. Mosmann TR, Coffman RL, et al.: TH1 and TH2 cells different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73
117. Finkelman FD, Pearce EJ, Urban JF, et al.: Regulation and biological function of helminth-induced cytokine responses. Immunol Today 1991; 12:A62-6
118. Nakajima H, Iwamoto I, Tomoe S, et al.: CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146:374-7
119. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistence and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76
120. Scott P. IL-12: Initiation cytokine for cell mediated immunity. Science 1993; 260:496-7
121. Manetti R, Parronchi P, Giudizi MG, et al.: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993; 177:1199-204
122. Constant SL, Bottomly K: Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15:297-322
123. Kingsley D: The TGF-β superfamily: New members, new receptors and new genetic tests of function in different organisms. Genes Dev 1994; 8:133
124. Wahl SM: Transforming growth factor beta: The good, the bad, and the ugly. J Exp Med 1994; 180:1587-90
125. Yoshida A, Koide Y, Uchijima M, et al.: IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem Biophys Res Commun 1994; 198:857-61
126. Hsieh CS, Macatonia SE, Tripp CS, et al.: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260:547-9
127. O'Garra A, Hosken N, Macatonia S, et al.: The role of macrophage- and dendritic cell-derived IL-12 in Th 1 phenotype development. Res Immunol 1995; 146:466-72
128. Schijns VE, Wierda CM, van Hoeij M, et al.: Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. J Immunol 1996; 157:815-21
129. Morshed SA, Fukuma H, Kimura Y, et al.: Interferon-gamma, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver. Gastroenterol Jpn 1993; 28(Suppl)5:59-66
130. Lotzova E, Ades EW: Natural killer cells: Definition, heterogeneity, lytic mechanism, functions and clinical and application. Mat Immunol Cell Growth Regul 1989; 8:1-9
131. Arancia G, Malorni W, Donelli G, et al.: Cellular mechanisms of lymphocyte-mediated lysis of tumor cells. Ann Ist Super Sanità 1990; 26:369-84
132. Gong Y, Guo X, Zhang X. Immunoelectron microscopic studies on the process of tumor cytolysis mediated by lymphokine activated NK cells. Chung Hua Ping Li Hsueh Tsa Chih 1994; 23:17-9
133. D'Andrea A, Rengaraju M, Valiante NM, et al.: Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J Exp Med 1992; 176:1387-98
134. Trapani J. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perform, and the serine protease, granzyme B. Aust N Z J Med 1995; 25:793-9
135. Bomn HG: Peptide antibiotics and their role in innate immunity. Ann Rev Immunol 1995; 13:61-92
136. Malorni W, Iosi F, Zarcone D, et al.: Role of adhesion molecules in the mechanism of non-MHC (major histocompatibility complex) restricted cell-mediated cytotoxicity. Scanning Microsc 1993; 7:323-332
137. Zarcone D, Viale O, Cerruti G, et al.: Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing they activation. Cell Immunol 1992; 143:389-404
138. Knight C, Rees R, Platts A, et al.: Interleukin-2 activated human effector lymphocytes mediate cytotoxicity inducing apoptosis in human leukaemia and solid tumour target cells. Immunology 1993; 79:535-41